Company / Named in our posts
Abpro Corporation.
Follow Abpro CorporationAbpro Corporation is a biotechnology company developing next-generation antibody therapeutics using proprietary discovery and engineering platforms.[1]
01Deal
Deals on Carrywatch
Every deal that names Abpro Corporation, and its role in each.
Atlantic Coastal Acquisition Corp. II / Abpro Corporation
Atlantic Coastal Acquisition Corp. II combines with Abpro Corporation
See deal detailsDeal Web
Abpro Corporation and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
4 fiscal years of figures as Abpro Corporation reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Abpro Corporation Financial Statements for the Period Ended September 30, 2024
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Abpro Corporation:
- P01